LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 59.42 | 21.74 | 3277 | 6125 | 0.5350 | 0.8520 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.39 | 21.74 | 3558 | 6112 | 0.5821 | 0.8713 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.39 | 21.74 | 3579 | 6112 | 0.5855 | 0.8726 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.39 | 21.74 | 327 | 6112 | 0.0535 | 0.3955 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 62.39 | 21.74 | 3459 | 6112 | 0.5659 | 0.8648 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.36 | 21.74 | 3730 | 6191 | 0.6025 | 0.8795 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.36 | 21.74 | 3756 | 6191 | 0.6067 | 0.8811 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.36 | 21.74 | 319 | 6191 | 0.0515 | 0.3902 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 64.36 | 21.74 | 3641 | 6191 | 0.5881 | 0.8739 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 66.33 | 21.74 | 3901 | 6235 | 0.6256 | 0.8883 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 66.33 | 21.74 | 3917 | 6235 | 0.6282 | 0.8893 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 66.33 | 21.74 | 373 | 6235 | 0.0598 | 0.4165 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 66.33 | 21.74 | 3818 | 6235 | 0.6123 | 0.8834 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 68.30 | 21.74 | 4085 | 6244 | 0.6542 | 0.8987 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 68.30 | 21.74 | 4102 | 6244 | 0.6569 | 0.8997 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 68.30 | 21.74 | 398 | 6244 | 0.0637 | 0.4276 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 68.30 | 21.74 | 3998 | 6244 | 0.6402 | 0.8937 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.27 | 21.74 | 4265 | 6201 | 0.6877 | 0.9103 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.27 | 21.74 | 4283 | 6201 | 0.6906 | 0.9113 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.27 | 21.74 | 462 | 6201 | 0.0745 | 0.4546 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.27 | 21.74 | 4139 | 6201 | 0.6674 | 0.9033 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.24 | 21.74 | 4477 | 6162 | 0.7266 | 0.9231 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.24 | 21.74 | 4488 | 6162 | 0.7283 | 0.9237 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.24 | 21.74 | 445 | 6162 | 0.0722 | 0.4486 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.24 | 21.74 | 4233 | 6162 | 0.6870 | 0.9099 | MN20160310_N01 | N13 |